comprehensive -WSS

comprehensive

author：focus 2025-09-27 21:28:01 - browse：33224

Abbott's heart device TriClip on a gradient dark blue background — coverage from STAT — The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. Illustration: STAT; Photo: Courtesy Abbott

An advisory panel to the Food and Drug Administration voted in favor of a new device from Abbott meant to treat patients with tricuspid heart valve disease. All but one of the 14 panelists said the treatment’s benefits outweighed its risks. The FDA tends to follow advisory panel recommendations.

“If we can help symptoms with this at a low cost in terms of risk, I think it makes a lot of sense,” said James Blankenship, a panelist and cardiologist at the University of New Mexico.

The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. The condition impacts 1.6 million people in the United States. Symptoms include fatigue, swelling, and atypical heart rhythms. In severe cases, the condition can lead to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： NIH tests clinical research in primary care with $30 million program

hotspot

WSS

Why doctors need education on FDA device approval process

Cheap, fast test for Zika and dengue could cost just $1

Copay coupons to count toward deductibles, after Biden court move

Prior authorization will have to move faster under new Biden rule

'Essentially witchcraft:' A former naturopath takes on the field

Independent physicians launch a new lobbying group

focus

comprehensive

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The system is set up to fail children with medical complexity

As demand for Covid shots wanes, Moderna seeks its next success

Teladoc has a new CEO, but challenges remain the same

Hollywood unions extend contract negotiations for actors

Dewpoint Therapeutics lays off staff after losing partnerships

Medical records are filled with copy

Copay coupons to count toward deductibles, after Biden court move

Medicare proposal to cover medical devices draws a mixed reaction

Elizabeth Holmes banned from government health programs

hotspot

Research misconduct: Proposed new rules face resistance

My daughter's legacy lives on through her writing, phage therapy

Readers discuss the intersection of pregnancy and addiction

Teladoc has a new CEO, but challenges remain the same

How faith leaders like me can help address America's obesity epidemic

Lilly's Alzheimer's drug donanemab backed by FDA advisers

explore

hotspot

hotspot

focus